Skip to main content

Advertisement

Log in

Managing ESBL-producing Enterobacteriaceae-related urinary tract infection in primary care: a tool kit for general practitioners

  • Original Article
  • Published:
European Journal of Clinical Microbiology & Infectious Diseases Aims and scope Submit manuscript

Abstract

In Southern France, approximately 4% of E. coli isolates from community-acquired urinary tract infections are extended spectrum beta-lactamase producers, while carriage rates for enterobacteriaceae (ESBL-E) range from 3 to 6%. General practitioners (GP) are unfamiliar with the management of patients harboring ESBL-E. Providing them with a specific tool kit should assist in their therapeutic approach and optimize antimicrobial prescription an ESBL-E tool kit was developed by a multidisciplinary team: infectious diseases (ID) specialists, microbiologists, pharmacologists, and nursing home staff. This tool kit includes treatment protocols, GP and patient information leaflets, a list of infection control measures, and contact details of ID physicians for specialized advice. A community-based (including nursing homes) prospective study was conducted in 2012 in Southeastern France to test the tool kit in the context of ESBL-E-related urinary tract infections (UTI). ESBL-E-related UTI were identified in 88 patients, 66 GPs were contacted by the microbiology laboratory, 56 stated they were offered the tool kit, 48 said they had received it, and 41 stated they had read its contents. Use of the tool kit was significantly correlated with appropriate antibiotic prescription, which concerned 36/39 tool kit users versus 13/20 non-users (p = 0.0125) and 40 GPs expressed an average satisfaction rate of 4.2 on a scale of 0 to 5. Availability of a specific tool for managing patients harboring ESBL-E, now completed with a website, can assist community-based GPs and improve antimicrobial prescription.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Rossotti R, Orani A (2012) Clinical management of ESBL-producing Enterobacteriaceae: the insidious role of fluoroquinolones. Eur J Clin Microbiol Infect Dis 31(7):1517–1522. https://doi.org/10.1007/s10096-011-1472-y

    Article  CAS  PubMed  Google Scholar 

  2. De Rosa FG, Pagani N, Fossati L, Raviolo S, Cometto C, Cavallerio P, Parlato C, Guglielmi E, Serra R, Di Perri G (2011) The effect of inappropriate therapy on bacteremia by ESBL-producing bacteria. Infection 39(6):555–561. https://doi.org/10.1007/s15010-011-0201-x

    Article  CAS  PubMed  Google Scholar 

  3. Cantón R, Novais A, Valverde A, Machado E, Peixe L, Baquero F, Coque TM (2008) Prevalence and spread of extended-spectrum beta-lactamase-producing Enterobacteriaceae in Europe. Clin Microbiol Infect 14(Suppl 1):144–153

    Article  PubMed  Google Scholar 

  4. Trépos JY, Laure P (2008) General practioners and medical guidelines: a sociological approach. [article in French]. Rev Epidemiol Sante Publique 56(Suppl 3):S221–S229. https://doi.org/10.1016/j.respe.2008.04.007

    Article  PubMed  Google Scholar 

  5. Giry M, Pulcini C, Rabaud C, Boivin JM, Mauffrey V, Birgé J (2016) Acceptability of antibiotic stewardship measures in primary care. Med Mal Infect 46(6):276–284. https://doi.org/10.1016/j.medmal.2016.02.001

    Article  CAS  PubMed  Google Scholar 

  6. Bourdellon L, Thilly N, Fougnot S, Pulcini C, Henard S (2017) Impact of selective reporting of antibiotic susceptibility test results on the appropriateness of antibiotics chosen by French general practitioners in urinary tract infections: a randomised controlled case-vignette study. Int J Antimicrob Agents 50(2):258–262. https://doi.org/10.1016/j.ijantimicag.2017.01.040

    Article  CAS  PubMed  Google Scholar 

  7. Chervet D, Lortholary O, Zahar JR, Dufougeray A, Pilmis B, Partouche H (2017) Antimicrobial resistance in community-acquired urinary tract infections in Paris in 2015. Med Mal Infect. https://doi.org/10.1016/j.medmal.2017.09.013

  8. Jaffe A, Yoselis A, Tripto-Shkolnik L (2015) Better together: a community-hospital integrative model of healthcare as a practical solution for providing excellence in endocrinology care in an era of limited resources. Isr J Health Policy Res 4:28. https://doi.org/10.1186/s13584-015-0024-9. eCollection 2015.

  9. Björkman I, Berg J, Viberg N, Stålsby Lundborg C (2013) Awareness of antibiotic resistance and antibiotic prescribing in UTI treatment: a qualitative study among primary care physicians in Sweden. Scand J Prim Health Care 31(1):50–55. https://doi.org/10.3109/02813432.2012.751695

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

Our thanks to Brigitte Dunais for her assistance in the preparation of this manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Véronique Mondain.

Ethics declarations

Conflicts of interest

The authors declare that they have no conflicts of interest.

Ethical approval

For this type of study, ethical approval was not required.

Informed consent

Informed consent was not required for this study.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zucconi, A., Courjon, J., Maruéjouls, C. et al. Managing ESBL-producing Enterobacteriaceae-related urinary tract infection in primary care: a tool kit for general practitioners. Eur J Clin Microbiol Infect Dis 37, 983–986 (2018). https://doi.org/10.1007/s10096-018-3229-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10096-018-3229-3

Keywords

Navigation